Shigeru Fujimura

3.0k total citations
157 papers, 1.9k citations indexed

About

Shigeru Fujimura is a scholar working on Industrial and Manufacturing Engineering, Infectious Diseases and Epidemiology. According to data from OpenAlex, Shigeru Fujimura has authored 157 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Industrial and Manufacturing Engineering, 24 papers in Infectious Diseases and 22 papers in Epidemiology. Recurrent topics in Shigeru Fujimura's work include Scheduling and Optimization Algorithms (40 papers), Advanced Manufacturing and Logistics Optimization (21 papers) and Antibiotics Pharmacokinetics and Efficacy (20 papers). Shigeru Fujimura is often cited by papers focused on Scheduling and Optimization Algorithms (40 papers), Advanced Manufacturing and Logistics Optimization (21 papers) and Antibiotics Pharmacokinetics and Efficacy (20 papers). Shigeru Fujimura collaborates with scholars based in Japan, China and United States. Shigeru Fujimura's co-authors include Atsushi Nakadaira, Akira Watanabe, Hiroki Watanabe, Seiichi Kato, Jay Kishigami, Akihito Akutsu, Wei Weng, Yasuhiko Miyazaki, Kazuie Iinuma and Takeshi Kawamura and has published in prestigious journals such as SHILAP Revista de lepidopterología, The FASEB Journal and Journal of Bacteriology.

In The Last Decade

Shigeru Fujimura

144 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shigeru Fujimura Japan 22 502 427 260 252 225 157 1.9k
Mahfooz Alam India 17 262 0.5× 155 0.4× 21 0.1× 199 0.8× 286 1.3× 78 962
Sigurður Ólafsson United States 25 151 0.3× 113 0.3× 470 1.8× 42 0.2× 167 0.7× 97 2.5k
José M. Such Spain 40 399 0.8× 1.1k 2.7× 11 0.0× 527 2.1× 195 0.9× 212 5.8k
Danfeng Sun China 19 53 0.1× 311 0.7× 90 0.3× 235 0.9× 96 0.4× 83 3.3k
Manjit Kaur India 27 129 0.3× 79 0.2× 25 0.1× 128 0.5× 167 0.7× 88 2.1k
Xing Pan China 24 32 0.1× 92 0.2× 186 0.7× 42 0.2× 52 0.2× 117 1.8k
Damien Dubois France 26 51 0.1× 190 0.4× 13 0.1× 372 1.5× 36 0.2× 73 2.9k
Xiaofang Liu China 24 618 1.2× 23 0.1× 210 0.8× 330 1.3× 685 3.0× 86 2.4k
Haihui Huang China 23 41 0.1× 155 0.4× 22 0.1× 573 2.3× 19 0.1× 84 1.6k
B. Kumar India 29 14 0.0× 234 0.5× 58 0.2× 250 1.0× 200 0.9× 241 3.4k

Countries citing papers authored by Shigeru Fujimura

Since Specialization
Citations

This map shows the geographic impact of Shigeru Fujimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeru Fujimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeru Fujimura more than expected).

Fields of papers citing papers by Shigeru Fujimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeru Fujimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeru Fujimura. The network helps show where Shigeru Fujimura may publish in the future.

Co-authorship network of co-authors of Shigeru Fujimura

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeru Fujimura. A scholar is included among the top collaborators of Shigeru Fujimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeru Fujimura. Shigeru Fujimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sato, Tetsu, Shigeru Fujimura, Kae Nakamura, et al.. (2024). The expression of intestinal Cyp2c55 is regulated by the microbiota and inflammation. The FASEB Journal. 38(20). e70117–e70117.
2.
Sato, Takumi, et al.. (2024). Total Synthesis and Antibacterial Activity of Marine Tris-indole Alkaloid Tulongicin A. Journal of Natural Products. 87(6). 1556–1562. 3 indexed citations
3.
Takada, Keisuke, Naoki Hirose, Fumio Nagumo, et al.. (2023). Comparison of the efficacy and safety of standard‐ and high‐dose daptomycin: A systematic review and meta‐analysis. British Journal of Clinical Pharmacology. 89(4). 1291–1303. 4 indexed citations
4.
Fujimura, Shigeru, et al.. (2021). Comparison of Pharmaceutical Characteristics between Brand-Name Meropenem and Its Generics. Antibiotics. 10(9). 1096–1096. 1 indexed citations
5.
Hayakawa, Sachiko, M. Kawamura, Takumi Sato, et al.. (2018). An α-Lipoic acid derivative, and anti-ROS agent, prevents the acquisition of multi-drug resistance in clinical isolates of Pseudomonas aeruginosa. Journal of Infection and Chemotherapy. 25(1). 28–33. 5 indexed citations
6.
Watanabe, Hiroki, et al.. (2017). Technology and Challenges of Blockchain Platforms. IEICE Technical Report; IEICE Tech. Rep.. 117(114). 21–26. 1 indexed citations
7.
Fujimura, Shigeru, et al.. (2015). W3C TPAC 2014 Report and HTML5 Recommendation. NTT technical review. 13(5). 39–44. 1 indexed citations
8.
Fujimura, Shigeru, Yoshihisa Nakano, & Akira Watanabe. (2014). A correlation between reduced susceptibilities to vancomycin and daptomycin among the MRSA isolates selected in mutant selection window of both vancomycin and daptomycin. Journal of Infection and Chemotherapy. 20(12). 752–756. 6 indexed citations
9.
Fujimura, Shigeru & Akira Watanabe. (2012). Generic antibiotics in Japan. Journal of Infection and Chemotherapy. 18(4). 421–427. 15 indexed citations
10.
Fujimura, Shigeru, Kazunori Gomi, Yoshihisa Nakano, et al.. (2009). Susceptibility to arbekacin of clinical strains of Pseudomonas aeruginosa isolated in the Tohoku area between 2003 and 2007. 57(2). 91–96. 2 indexed citations
11.
Fujimura, Shigeru, Tetsuro Sato, Takeshi Mikami, et al.. (2008). Combined efficacy of clarithromycin plus cefazolin or vancomycin against Staphylococcus aureus biofilms formed on titanium medical devices. International Journal of Antimicrobial Agents. 32(6). 481–484. 34 indexed citations
12.
Fujimura, Shigeru, et al.. (2007). Relationship between the usage of carbapenem antibiotics and the incidence of imipenem-resistant Pseudomonas aeruginosa. Journal of Infection and Chemotherapy. 13(3). 147–150. 16 indexed citations
13.
Kato, Seiichi, et al.. (2006). Non-Helicobacter Bacterial Flora Rarely Develops in the Gastric Mucosal Layer of Children. Digestive Diseases and Sciences. 51(4). 641–646. 28 indexed citations
14.
Fujimura, Shigeru, et al.. (2004). Survey of methicillin-resistant Staphylococcus aureus from neonates and the environment in the NICU. Journal of Infection and Chemotherapy. 10(2). 131–132. 19 indexed citations
15.
Fujimura, Shigeru, et al.. (2004). In vitro exposure to macrolide antibiotics in Helicobacter pylori strains isolated from children. Journal of Infection and Chemotherapy. 10(2). 128–130. 3 indexed citations
16.
Ohkouchi, Shinya, Kazunori Gomi, Yutaka Tokue, et al.. (2004). Sepsis caused by methicillin-resistant Staphylococcus aureus (MRSA) without effects of vancomycin (VCM), teicoplanin (TEIC) and arbekacin (ABK) treated successfully and safely with intravenous administration of linezolid (LZD). 52(12). 787–792. 1 indexed citations
17.
Fujimura, Shigeru & Akira Watanabe. (2003). Survey of High- and Low-Level Mupirocin-Resistant Strains of Methicillin-Resistant <i>Staphylococcus aureus </i>in 15 Japanese Hospitals. Chemotherapy. 49(1-2). 36–38. 22 indexed citations
18.
Fujimura, Shigeru, Takeshi Kawamura, Seiichi Kato, Hiroo Tateno, & Akira Watanabe. (2002). Detection of Helicobacter pylori in cow's milk. Letters in Applied Microbiology. 35(6). 504–507. 54 indexed citations
19.
Watanabe, Akira, Tohru Kikuchi, Yutaka Tokue, et al.. (1999). In vitro antimicrobial activity and penetration rate into sputum of gatifloxacin, a novel 6-fluoro-8-methoxy quinolone, and its therapeutic efficacy in respiratory infections. Journal of Infection and Chemotherapy. 5(3). 149–155. 5 indexed citations
20.
Fujimura, Shigeru, et al.. (1990). AUK : Shell for Building Intelligent System Based on Object - oriented knowledge Representation auk. 31(1). 76–87.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mahfooz Alam Breakdown of academic impact, for papers by Sigurður Ólafsson Breakdown of academic impact, for papers by José M. Such Breakdown of academic impact, for papers by Danfeng Sun Breakdown of academic impact, for papers by Manjit Kaur Breakdown of academic impact, for papers by Xing Pan Breakdown of academic impact, for papers by Damien Dubois Breakdown of academic impact, for papers by Xiaofang Liu Breakdown of academic impact, for papers by Haihui Huang Breakdown of academic impact, for papers by B. Kumar
Rankless by CCL
2026